These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11422824)
21. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010 [TBL] [Abstract][Full Text] [Related]
22. Once-daily tacrolimus in liver transplantation: a 'me-too drug', or a therapeutic advantage. Trunečka P Curr Opin Organ Transplant; 2017 Apr; 22(2):118-122. PubMed ID: 28079558 [TBL] [Abstract][Full Text] [Related]
23. Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period. Kato H; Usui M; Muraki Y; Okuda M; Nakatani K; Hayasaki A; Ito T; Iizawa Y; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Isaji S Transplant Proc; 2018 Nov; 50(9):2684-2689. PubMed ID: 30401377 [TBL] [Abstract][Full Text] [Related]
24. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Inomata Y; Tanaka K; Egawa H; Uemoto S; Ozaki N; Okajima H; Satomura K; Kiuchi T; Yamaoka Y; Hashida T Transplantation; 1996 Jan; 61(2):247-52. PubMed ID: 8600632 [TBL] [Abstract][Full Text] [Related]
25. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. Mita A; Ikegami T; Masuda Y; Katsuyama Y; Ohno Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S Transplant Proc; 2014 Apr; 46(3):794-6. PubMed ID: 24767351 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978 [TBL] [Abstract][Full Text] [Related]
27. Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children. Reggiani P; Gridelli B; Colledan M; Rossi G; Lucianetti A; Galmarini D; Fassati LR Transpl Int; 1998; 11 Suppl 1():S272-4. PubMed ID: 9664995 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial. Undre N; Baccarani U; Britz R; Popescu I Ann Transplant; 2019 May; 24():268-272. PubMed ID: 31086126 [TBL] [Abstract][Full Text] [Related]
30. Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation. Jain A; Mohanka R; Orloff M; Abt P; Kashyap R; Kelley M; Burlee K; Bozorgzadeh A Exp Clin Transplant; 2005 Dec; 3(2):361-5. PubMed ID: 16417444 [TBL] [Abstract][Full Text] [Related]
31. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. Masuda S; Goto M; Okuda M; Ogura Y; Oike F; Kiuchi T; Tanaka K; Inui K Transplant Proc; 2005 May; 37(4):1728-9. PubMed ID: 15919446 [TBL] [Abstract][Full Text] [Related]
32. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. Bäckman L; Persson CA Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379 [TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583 [TBL] [Abstract][Full Text] [Related]
34. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation. Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838 [TBL] [Abstract][Full Text] [Related]
35. Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation. Moreno M; Manzanares C; Castellano F; Medina E; Urruzuno P; Camarena C; Manzanares J; Jara P Ther Drug Monit; 1998 Aug; 20(4):376-9. PubMed ID: 9712459 [TBL] [Abstract][Full Text] [Related]
36. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. Gruessner RW; Bartlett ST; Burke GW; Stock PG Clin Transplant; 1998 Jun; 12(3):260-2. PubMed ID: 9642520 [TBL] [Abstract][Full Text] [Related]
37. Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation. Ichikawa Y; Hanafusa T; Kyo M; Fukunishi T; Nagano S Int J Urol; 1996 May; 3(3):180-3. PubMed ID: 8776613 [TBL] [Abstract][Full Text] [Related]
38. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients. Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715 [TBL] [Abstract][Full Text] [Related]
39. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015 [TBL] [Abstract][Full Text] [Related]